| Infection regulates pro-resolving mediators that lower antibiotic requirements N Chiang, G Fredman, F Bäckhed, SF Oh, T Vickery, BA Schmidt, ... Nature 484 (7395), 524-528, 2012 | 712 | 2012 |
| Inflammation and its resolution as determinants of acute coronary syndromes P Libby, I Tabas, G Fredman, EA Fisher Circulation research 114 (12), 1867-1879, 2014 | 666 | 2014 |
| Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression A Ariel, G Fredman, YP Sun, A Kantarci, TE Van Dyke, AD Luster, ... Nature immunology 7 (11), 1209-1216, 2006 | 456 | 2006 |
| Resolvin D series and protectin D1 mitigate acute kidney injury JS Duffield, S Hong, VS Vaidya, Y Lu, G Fredman, CN Serhan, ... The Journal of Immunology 177 (9), 5902-5911, 2006 | 440 | 2006 |
| An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques G Fredman, J Hellmann, JD Proto, G Kuriakose, RA Colas, B Dorweiler, ... Nature communications 7 (1), 12859, 2016 | 396 | 2016 |
| Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice G Fredman, N Kamaly, S Spolitu, J Milton, D Ghorpade, R Chiasson, ... Science translational medicine 7 (275), 275ra20-275ra20, 2015 | 360 | 2015 |
| MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits A Recchiuti, S Krishnamoorthy, G Fredman, N Chiang, CN Serhan The FASEB Journal 25 (2), 544, 2011 | 338 | 2011 |
| Annexin A1–containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair G Leoni, PA Neumann, N Kamaly, M Quiros, H Nishio, HR Jones, ... The Journal of clinical investigation 125 (3), 1215-1227, 2015 | 321 | 2015 |
| Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs S Krishnamoorthy, A Recchiuti, N Chiang, G Fredman, CN Serhan The American journal of pathology 180 (5), 2018-2027, 2012 | 304 | 2012 |
| Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets M Dona, G Fredman, JM Schwab, N Chiang, M Arita, A Goodarzi, ... Blood, The Journal of the American Society of Hematology 112 (3), 848-855, 2008 | 295 | 2008 |
| The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apoptosis via lipid raft clustering A Ariel, PL Li, W Wang, WX Tang, G Fredman, S Hong, KH Gotlinger, ... Journal of Biological Chemistry 280 (52), 43079-43086, 2005 | 289 | 2005 |
| Mechanisms and consequences of defective efferocytosis in atherosclerosis A Yurdagul Jr, AC Doran, B Cai, G Fredman, IA Tabas Frontiers in cardiovascular medicine 4, 86, 2018 | 280 | 2018 |
| Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles N Kamaly, G Fredman, M Subramanian, S Gadde, A Pesic, L Cheung, ... Proceedings of the National Academy of Sciences 110 (16), 6506-6511, 2013 | 240 | 2013 |
| MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis B Cai, EB Thorp, AC Doran, BE Sansbury, MJAP Daemen, B Dorweiler, ... The Journal of clinical investigation 127 (2), 564-568, 2017 | 216 | 2017 |
| Resolvin E2 formation and impact in inflammation resolution SF Oh, M Dona, G Fredman, S Krishnamoorthy, D Irimia, CN Serhan The Journal of Immunology 188 (9), 4527-4534, 2012 | 212 | 2012 |
| Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis N Kamaly, G Fredman, JJR Fojas, M Subramanian, WII Choi, K Zepeda, ... ACS nano 10 (5), 5280-5292, 2016 | 208 | 2016 |
| Resolvin D1 limits 5-lipoxygenase nuclear localization and leukotriene B4 synthesis by inhibiting a calcium-activated kinase pathway G Fredman, L Ozcan, S Spolitu, J Hellmann, M Spite, J Backs, I Tabas Proceedings of the National Academy of Sciences 111 (40), 14530-14535, 2014 | 206 | 2014 |
| Boosting inflammation resolution in atherosclerosis: the next frontier for therapy G Fredman, I Tabas The American journal of pathology 187 (6), 1211-1221, 2017 | 202 | 2017 |
| Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution G Fredman, CN Serhan Biochemical Journal 437 (2), 185-197, 2011 | 200 | 2011 |
| MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation B Cai, EB Thorp, AC Doran, M Subramanian, BE Sansbury, CS Lin, ... Proceedings of the National Academy of Sciences 113 (23), 6526-6531, 2016 | 199 | 2016 |
Charles SerhanBrigham & Women's Hospital Harvard Medical SchoolVerified email at zeus.bwh.harvard.edu
